BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734
44262 results:

  • 1. Decomposing difference in the kidney cancer burden measures between 1990 and 2019 based on the global burden of disease study.
    Ayubi E; Shahbazi F; Khazaei S
    Sci Rep; 2024 May; 14(1):10390. PubMed ID: 38710935
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
    Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Renal and major clinical outcomes and their determinants after nephrectomy in patients with pre-existing chronic kidney disease: A retrospective cohort study.
    Schleef M; Roy P; Lemoine S; Paparel P; Colombel M; Badet L; Guebre-Egziabher F
    PLoS One; 2024; 19(5):e0300367. PubMed ID: 38696458
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Current State of Liver Transplantation for Cholangiocarcinoma: A Comprehensive Literature Review.
    Mansoor J; Heaton N; Junaid Z
    Exp Clin Transplant; 2024 Mar; 22(3):167-179. PubMed ID: 38695585
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Contrast-Enhanced Ultrasound as a Diagnostic Procedure in Renal Diseases: A Case Report.
    Sellitto S; Tarantino L; Barone F; Barone N; Perna A; Lucariello A; Guerra G; De Luca A; Filippelli A; Sellitto C
    G Ital Nefrol; 2024 Apr; 41(2):. PubMed ID: 38695227
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular and functional characterization of reversible-sunitinib-tolerance state in human renal cell carcinoma.
    Zaccagnino A; Vynnytska-Myronovska B; Stöckle M; Junker K
    J Cell Mol Med; 2024 May; 28(9):e18329. PubMed ID: 38693863
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Epidemiology, treatment and outcomes of primary renal sarcomas in adult patients.
    Uhlig J; Uhlig A; Deshpande H; Ströbel P; Trojan L; Lotz J; Hurwitz M; Hafez O; Humphrey P; Grünwald V; Kim HS
    Sci Rep; 2024 May; 14(1):10038. PubMed ID: 38693188
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Totally retroperitoneal approach for robot-assisted nephroureterectomy with bladder cuff without repositioning.
    Hattori Y; Yamamoto A; Nagoshi A; Fujiwara T; Kambe T; Igarashi A; Akagi N; Shibasaki N; Kawakita M; Yamasaki T
    Asian J Endosc Surg; 2024 Jul; 17(3):e13317. PubMed ID: 38692582
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
    Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
    BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. HECTD2/TNFAIP1 Axis Regulating the p38/JNK Pathway to Promote an Inflammatory Response in Renal Cell Carcinoma Cells.
    Lv D; Chen Y; Tang L; Tian Y; Ren D; Jian N; Shen T
    In Vivo; 2024; 38(3):1094-1103. PubMed ID: 38688591
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
    Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
    JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of hyperuricemia and chronic kidney disease on the prevalence and mortality of cardiovascular disease in cancer survivors.
    Chen Y; Chen Y; Lin W; Fu L; Liu H; Pu S; Chen H; Yi H; Xue Y
    Cancer Med; 2024 May; 13(9):e7180. PubMed ID: 38686569
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers.
    Smith-Byrne K; Hedman Å; Dimitriou M; Desai T; Sokolov AV; Schioth HB; Koprulu M; Pietzner M; Langenberg C; Atkins J; Penha RC; McKay J; Brennan P; Zhou S; Richards BJ; Yarmolinsky J; Martin RM; Borlido J; Mu XJ; Butterworth A; Shen X; Wilson J; Assimes TL; Hung RJ; Amos C; Purdue M; Rothman N; Chanock S; Travis RC; Johansson M; Mälarstig A
    Nat Commun; 2024 Apr; 15(1):3621. PubMed ID: 38684708
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sweet syndrome with peripheral neuropathy in a patient with metastatic clear cell renal cell carcinoma.
    Monkman R; Monfregola M; Waibel C; Scheidegger P
    BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38684355
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparison of the perioperative outcomes of robot-assisted laparoscopic transperitoneal versus retraperitoneal partial nephrectomy for posterior-lateral renal tumors: a systematic review and meta-analysis.
    Xu P; Luo J; Shuai H; Cai T; Cui S; Zhou L; Xu Q; Zhao Y; Chen T; Shan W; Wu T
    J Robot Surg; 2024 Apr; 18(1):186. PubMed ID: 38683492
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms' tumor.
    Guo Y; Lu W; Zhang Z; Liu H; Zhang A; Zhang T; Wu Y; Li X; Yang S; Cui Q; Li Z
    BMC Pediatr; 2024 Apr; 24(1):279. PubMed ID: 38678251
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Patient's self-reported quality of life as a prognostic factor in metastatic renal cell carcinoma initially treated with TKI: nomogram proposal.
    Lendínez-Cano G; Vilches-Arenas Á; Congregado-Ruíz B; Medina-López R
    World J Urol; 2024 Apr; 42(1):267. PubMed ID: 38678165
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.
    Pitakkitnukun P; Pongpitakmetha T; Suttichet TB; Sukkummee W; Chariyavilaskul P; Polprasert C
    Sci Rep; 2024 Apr; 14(1):9695. PubMed ID: 38678107
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.
    Scilipoti P; Rosiello G; Larcher A; Fallara G; Cignoli D; Re C; Musso G; Cei F; Tian Z; Karakiewicz PI; Mottrie A; Trevisani F; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
    World J Urol; 2024 Apr; 42(1):264. PubMed ID: 38676733
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2214.